Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001144204-12-067596
Filing Date
2012-12-12
Accepted
2012-12-12 14:19:24
Documents
1
Effectiveness Date
2012-12-12
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11923
  Complete submission text file 0001144204-12-067596.txt   13043
Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036
Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804
Morria Biopharmaceuticals PLC (Filer) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: D | Act: 33 | File No.: 021-188250 | Film No.: 121258716
SIC: 2834 Pharmaceutical Preparations